biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Unternehmens-codeBTMD
Name des UnternehmensBiote Corp
IPO-datumMar 02, 2021
Gegründet am2020
CEOMr. Bret Christensen
Anzahl der mitarbeiter217
WertpapierartOrdinary Share
GeschäftsjahresendeMar 02
Addresse1875 W. Walnut Hill Ln #100
StadtIRVING
BörseNASDAQ Global Market Consolidated
LandUnited States of America
Postleitzahl75038
Telefon19724869346
Websitehttps://haymakeracquisition.com/
Unternehmens-codeBTMD
IPO-datumMar 02, 2021
Gegründet am2020
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten